Answers are grounded in this paper and cite their sources.
The disease panels covered by newborn blood spot screening vary greatly from country to country. There are different interpretations of the Wilson and Jungner principles and of underlying data in the scientific literature, and great disparities between the value judgements applied in screening and in routine clinical practice.
No takes yet. Share an insight, caveat, or question.
R. J. Pollitt (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: